[Clinical importance of the leukocyte migration inhibition test in thyroid diseases]

The leukocyte migration inhibition test (LMIT) was used to examine a group of patients with autoimmune thyroiditis and diffuse toxic goiter. The LMIT is likely to be used as an additional histological test for evaluating the correlation between the cellular and humoral types of autoimmunity in thyroid diseases.